June 6, 2019 — Qiagen and DiaSorin are teaming up on the development of a more sensitive test to enable earlier detection of Lyme disease, with plans in 2020 to validate the diagnostic in trials and submit filings in the U.S. and Europe, the companies announced on June 5.